"Addressing the Disparity: Improving Access to Clinical Trials for Cancer Patients"

Less than 5% of cancer patients worldwide have access to clinical trials, hindering the progress in finding a cure for cancer. Dr. Bob Li, a physician ambassador and medical oncologist, emphasizes the need for global coordination and addressing the issue of inequity in access to breakthrough research. He believes that clinical trials are crucial in translating scientific discoveries into life-saving treatments, but the low percentage of patients participating in trials leads to an excessively long research and development timeline. Efforts are being made to improve access to trials, such as partnerships between institutions and harmonization of trials and drug approvals.